Additionally, three datasets from the mouse HCC models (including the diethylnitrosamine [DEN]‐induced, CCl4‐induced and HBV transgenic models) consistently showed a significant increase in the expression of Tbc1d31 in liver tumors compared to non‐tumor livers (Figure S2f, Supporting Information). This evidence concerns the gene TBC1D31 and hepatocellular carcinoma.